Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,406 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 298
Recruiting: 143
Ph III recruiting: 19
Growth YoY: −14%
Industry share: 35%
Top sponsor: City of Hope Medical Center
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (273)

clinicaltrialsPublishedShowing 151–200 of 365 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02650414	CD22 Redirected Autologous T Cells for ALL	active not recruiting	Phase 1	41	University of PennsylvaniaOTHER	1	Jul 7, 2026	clinicaltrials
NCT04447768	The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)	active not recruiting	Phase 2	100	Memorial Sloan Kettering Cancer CenterOTHER	1	Jul 7, 2026	clinicaltrials